Search

Maris R. Kessel

Examiner (ID: 14775, Phone: (571)270-7698 , Office: P/1759 )

Most Active Art Unit
1759
Art Unit(s)
1795, 1759, 1758, 1699
Total Applications
485
Issued Applications
239
Pending Applications
11
Abandoned Applications
232

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18158785 [patent_doc_number] => 20230025377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-26 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING PRURITUS [patent_app_type] => utility [patent_app_number] => 17/797643 [patent_app_country] => US [patent_app_date] => 2021-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14606 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17797643 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/797643
COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING PRURITUS Feb 11, 2021 Abandoned
Array ( [id] => 16873955 [patent_doc_number] => 20210167422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-03 [patent_title] => LIQUID ELECTROLYTE FOR BATTERY [patent_app_type] => utility [patent_app_number] => 17/172760 [patent_app_country] => US [patent_app_date] => 2021-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3054 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17172760 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/172760
Liquid electrolyte for battery Feb 9, 2021 Issued
Array ( [id] => 16870048 [patent_doc_number] => 20210163515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-03 [patent_title] => BENFOTIAMINE DERIVATIVES IN THE TREATMENT OF ALZHEIMER'S DISEASE [patent_app_type] => utility [patent_app_number] => 17/173059 [patent_app_country] => US [patent_app_date] => 2021-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5993 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17173059 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/173059
Benfotiamine derivatives in the treatment of alzheimer's disease Feb 9, 2021 Issued
Array ( [id] => 16869990 [patent_doc_number] => 20210163457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-03 [patent_title] => CANAGLIFLOZIN MONOHYDRATE AND ITS CRYSTALLINE FORMS, PREPARATION METHODS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/172861 [patent_app_country] => US [patent_app_date] => 2021-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15117 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17172861 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/172861
CANAGLIFLOZIN MONOHYDRATE AND ITS CRYSTALLINE FORMS, PREPARATION METHODS AND USES THEREOF Feb 9, 2021 Abandoned
Array ( [id] => 19043570 [patent_doc_number] => 11932654 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-03-19 [patent_title] => Nimbolide analogs as anti-cancer agents and preparation thereof [patent_app_type] => utility [patent_app_number] => 17/171276 [patent_app_country] => US [patent_app_date] => 2021-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7147 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17171276 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/171276
Nimbolide analogs as anti-cancer agents and preparation thereof Feb 8, 2021 Issued
Array ( [id] => 18349782 [patent_doc_number] => 20230137893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => PYRROLO[2,3-b]PYRIDINE-3-CARBOXAMIDE COMPOSITIONS AND METHODS FOR AMELIORATING HEARING LOSS [patent_app_type] => utility [patent_app_number] => 17/760143 [patent_app_country] => US [patent_app_date] => 2021-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33042 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17760143 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/760143
PYRROLO[2,3-b]PYRIDINE-3-CARBOXAMIDE COMPOSITIONS AND METHODS FOR AMELIORATING HEARING LOSS Feb 4, 2021 Pending
Array ( [id] => 18329191 [patent_doc_number] => 11634419 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-04-25 [patent_title] => Dimethyl amino azetidine amides as JAK inhibitors [patent_app_type] => utility [patent_app_number] => 17/248717 [patent_app_country] => US [patent_app_date] => 2021-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24194 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17248717 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/248717
Dimethyl amino azetidine amides as JAK inhibitors Feb 3, 2021 Issued
Array ( [id] => 16854883 [patent_doc_number] => 20210155628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-27 [patent_title] => Heterocyclic Compounds as RET Kinase Inhibitors [patent_app_type] => utility [patent_app_number] => 17/165151 [patent_app_country] => US [patent_app_date] => 2021-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38370 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17165151 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/165151
Heterocyclic compounds as RET kinase inhibitors Feb 1, 2021 Issued
Array ( [id] => 18241117 [patent_doc_number] => 20230073428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-09 [patent_title] => METHODS OF TREATING AND ASSESSING PULMONARY ARTERIAL HYPERTENSION WITH SELEXIPAG [patent_app_type] => utility [patent_app_number] => 17/759467 [patent_app_country] => US [patent_app_date] => 2021-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19069 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17759467 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/759467
METHODS OF TREATING AND ASSESSING PULMONARY ARTERIAL HYPERTENSION WITH SELEXIPAG Feb 1, 2021 Abandoned
Array ( [id] => 16839442 [patent_doc_number] => 20210147454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-20 [patent_title] => COT MODULATORS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/162754 [patent_app_country] => US [patent_app_date] => 2021-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26534 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17162754 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/162754
Cot modulators and methods of use thereof Jan 28, 2021 Issued
Array ( [id] => 17050602 [patent_doc_number] => 20210260036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-26 [patent_title] => METHODS OF TREATMENT FOR ALPHA-1 ANTITRYPSIN DEFICIENCY [patent_app_type] => utility [patent_app_number] => 17/162129 [patent_app_country] => US [patent_app_date] => 2021-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16911 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17162129 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/162129
METHODS OF TREATMENT FOR ALPHA-1 ANTITRYPSIN DEFICIENCY Jan 28, 2021 Abandoned
Array ( [id] => 20505875 [patent_doc_number] => 12540142 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-02-03 [patent_title] => Method for evaluating quality of (3S)-3-(4-(3-(1,4-dioxaspiro[4,5]dec-7-en-8-yl)benzyloxy)phenyl)hex-4-inoic acid [patent_app_type] => utility [patent_app_number] => 17/759305 [patent_app_country] => US [patent_app_date] => 2021-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 383 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17759305 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/759305
METHOD FOR EVALUATING QUALITY OF (3S)-3-(4-(3-(1,4-DIOXASPIRO[4,5]DEC-7-EN-8-YL)BENZYLOXY)PHENYL)HEX-4-INOIC ACID Jan 28, 2021 Issued
Array ( [id] => 18320275 [patent_doc_number] => 20230118403 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-20 [patent_title] => PROPYLENE OXIDE PRODUCTION APPARATUS AND PROPYLENE OXIDE PRODUCTION METHOD [patent_app_type] => utility [patent_app_number] => 17/909596 [patent_app_country] => US [patent_app_date] => 2021-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19315 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 206 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17909596 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/909596
PROPYLENE OXIDE PRODUCTION APPARATUS AND PROPYLENE OXIDE PRODUCTION METHOD Jan 27, 2021 Pending
Array ( [id] => 17761467 [patent_doc_number] => 20220235079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-28 [patent_title] => Crystalline Forms of Tenofovir Alafenamide [patent_app_type] => utility [patent_app_number] => 17/159238 [patent_app_country] => US [patent_app_date] => 2021-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7994 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17159238 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/159238
Crystalline forms of Tenofovir alafenamide Jan 26, 2021 Issued
Array ( [id] => 16824156 [patent_doc_number] => 20210139449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-13 [patent_title] => CONVERSION OF CANNABIDIOL OR DELTA-9 TETRAHYDROCANNABINOLIC ACID TO DELTA-9 TETRAHYDROCANNABINOL AND DELTA-8 TETRAHYDROCANNABINOL IN NONTOXIC HETEROGENEOUS MIXTURES [patent_app_type] => utility [patent_app_number] => 17/157078 [patent_app_country] => US [patent_app_date] => 2021-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5673 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17157078 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/157078
CONVERSION OF CANNABIDIOL OR DELTA-9 TETRAHYDROCANNABINOLIC ACID TO DELTA-9 TETRAHYDROCANNABINOL AND DELTA-8 TETRAHYDROCANNABINOL IN NONTOXIC HETEROGENEOUS MIXTURES Jan 24, 2021 Abandoned
Array ( [id] => 16839376 [patent_doc_number] => 20210147388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-20 [patent_title] => IMIDAZOLYL KINASE INHIBITORS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/155244 [patent_app_country] => US [patent_app_date] => 2021-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41543 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -70 [patent_words_short_claim] => 559 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17155244 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/155244
Imidazolyl kinase inhibitors and uses thereof Jan 21, 2021 Issued
Array ( [id] => 19904114 [patent_doc_number] => 12281110 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-04-22 [patent_title] => Processes for preparing an FGFR inhibitor [patent_app_type] => utility [patent_app_number] => 17/155726 [patent_app_country] => US [patent_app_date] => 2021-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 18 [patent_no_of_words] => 8619 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17155726 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/155726
Processes for preparing an FGFR inhibitor Jan 21, 2021 Issued
Array ( [id] => 18308010 [patent_doc_number] => 20230111910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-13 [patent_title] => PD-1/PD-L1 INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/794390 [patent_app_country] => US [patent_app_date] => 2021-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20624 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17794390 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/794390
PD-1/PD-L1 INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF Jan 20, 2021 Pending
Array ( [id] => 18270225 [patent_doc_number] => 20230091467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-23 [patent_title] => FUSED RING SUBSTITUTED AROMATIC COMPOUND AND PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION, AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/437192 [patent_app_country] => US [patent_app_date] => 2021-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26925 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17437192 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/437192
Fused ring substituted aromatic compound and preparation method therefor, herbicidal composition, and use thereof Jan 11, 2021 Issued
Array ( [id] => 16945900 [patent_doc_number] => 20210204591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => TERPENES AND THC COMPOSITIONS AND METHODS [patent_app_type] => utility [patent_app_number] => 17/248047 [patent_app_country] => US [patent_app_date] => 2021-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11490 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17248047 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/248047
TERPENES AND THC COMPOSITIONS AND METHODS Jan 5, 2021 Pending
Menu